Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …

Aim Recent reports of potential harmful effects of nonsteroidal anti‐inflammatory drugs
(NSAIDs) in treating patients with coronavirus disease 2019 (COVID‐19) have raised great …

Background There are concerns that the use of non-steroidal anti-inflammatory drugs
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …

Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce
pain, fever, and inflammation but have been associated with complications in community …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly
used drugs, and have a wide range of uses. NSAIDs include nonselective cyclooxygenase …

Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from
aggressive inflammation initiated by viral replication. There has been much speculation …

Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used in patients with
respiratory infection, but their safety in coronavirus disease 19 (Covid-19) patients has not …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was
speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to …